Pharmaceutical industry – Page 20
-
BusinessEmerging from the US opioid crisis
With litigation against suppliers in full swing, how does the US counter its addiction to powerful painkillers?
-
ArticleHow possible contaminants are investigated
The analytical stages when a suspected issue is found in a product
-
-
ArticleHow biologics have changed the rules for pharma
The impact of the latest generation of drugs for the healthcare industry
-
PodcastLimulus Amebocyte Lysate
Frances Addison takes a look at the discovery that brought horseshoe crabs to the heart of the pharmaceutical industry
-
OpinionThe case for South Africa as the next pharma hub
Flow chemistry could drive regional manufacturing in Africa
-
OpinionShow me the data
Making industrial safety research more transparent benefits both companies and consumers
-
FeatureMalaria no more?
Efforts to cure malaria have been going on for hundreds of years. Clare Sansom looks at some of the latest – and most innovative
-
PodcastLevothyroxine
Kit Chapman investigates the drug that has been one of the top five prescription medications in the UK every year for the last two decades
-
Opinion
Management by numbers
Reducing intellectual processes to metrics runs the risk of people working to the numbers not the goal
-
-
BusinessBuilding a biological biocide
Aqualution Systems produces stable hypochlorous acid, a natural biocide up to 300 times more effective than bleach
-
NewsWhy jury verdicts get overruled in US industry cancer trials
Judges often end up intervening post-trial in complex cases with conflicting scientific evidence
-
NewsWindow of opportunity to deal with harmful chemicals closing, UN warns
Innovative solutions needed as report acknowledges governments and businesses won’t hit 2020 targets
-
-
ResearchCo-crystals fish out cannabinoid from plant extract
Purifying cannabidiol from natural cannabis extract made cheap and easy thanks to amino acid partner
-
BusinessNurturing the next biotech generation
As incubator environments evolve, options for new companies looking for support are broadening
-
ArticleSmall particles making a big splash in clinical development
Nanoform is investigating how to tackle clinical attrition rates through nanonisation of APIs
-
ArticleInvestigating multi-dimensional problems in drug substance development
Finding solutions to the biggest challenges faced during drug substance development relies on properly integrating analytical and production expertise
-
NewsEU sets goal of tackling pharmaceutical pollution in the environment
Commission identifies six areas to take action on